Zhang et al. constructed an AD rat model by intrathecal injection of Aβ-42 peptide, and they found that Th17 cells entered into the CNS with the disruption of the BBB, and levels of IL-17 and RORγt were increased in the hippocampus, CSF, and serum [87]. The gene discussed is IL17A; the disease is Alzheimer disease.